Fifty 1 Labs, Inc. NWAU
OTC PK
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -100.00% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -100.00% | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 653.13% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 653.13% | ||||
| Operating Income | -665.08% | ||||
| Income Before Tax | -665.08% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -665.08% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -665.08% | ||||
| EBIT | -665.08% | ||||
| EBITDA | -- | ||||
| EPS Basic | -- | ||||
| Normalized Basic EPS | -- | ||||
| EPS Diluted | -- | ||||
| Normalized Diluted EPS | -- | ||||
| Average Basic Shares Outstanding | 22.42% | ||||
| Average Diluted Shares Outstanding | 22.42% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||